COMMUNIQUÉS West-GlobeNewswire
-
Strongbridge Biopharma plc Enters into Agreement for Novo Nordisk to Acquire the U.S. and Canadian Rights to MACRILEN™ (macimorelin)
31/10/2018 - 13:45 -
Marrone Bio Innovations to Report Third Quarter 2018 Financial Results on Tuesday, November 13th at 4:30 p.m. Eastern Time
31/10/2018 - 13:31 -
Laura Clague Named to Fluidigm Board of Directors
31/10/2018 - 13:30 -
Arbutus to Report Third Quarter 2018 Financial Results
31/10/2018 - 13:30 -
Tower One October Update
31/10/2018 - 13:30 -
Director/PDMR Shareholding
31/10/2018 - 13:15 -
Catalyst Pharmaceuticals to Hold Third Quarter Financial Results and Corporate Update Conference Call and Webcast on Thursday, November 8th, 2018
31/10/2018 - 13:03 -
Nexstim Plc: Invitation to the Extraordinary General Meeting
31/10/2018 - 13:02 -
Nuvectra® to Participate in Two Upcoming Investor Conferences
31/10/2018 - 13:01 -
Study: Liberals and news junkies on edge as midterms approach
31/10/2018 - 13:00 -
CASMED Reports Third-Quarter 2018 Financial Results
31/10/2018 - 13:00 -
Chembio to Report Third Quarter 2018 Financial Results on November 8, 2018
31/10/2018 - 13:00 -
Sun BioPharma, Inc. Announces Leadership Changes
31/10/2018 - 13:00 -
Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference
31/10/2018 - 13:00 -
HempAmericana Readies to Launch its Own Proprietary CBD Oil
31/10/2018 - 13:00 -
Anchiano Therapeutics Announces Confidential Submission of Draft Registration Statement for U.S. Initial Public Offering
31/10/2018 - 13:00 -
Momenta Pharmaceuticals Announces Date of Third Quarter 2018 Financial Results Conference Call and Webcast
31/10/2018 - 13:00 -
Enzymatica AB: Breakthrough agreement for Japan and lower sales in Q3 due to restrictions in Germany
31/10/2018 - 08:31 -
Verona Pharma Completes Enrollment in Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment
31/10/2018 - 08:00
Pages